Board of Directors

Gérard Hascoët,
Chairman of the Board of CorWave

As a “serial entrepreneur” of medical devices, he founded companies such as Technomed International, IMMI and Sometec, all of which were acquired or floated on the stock market. Gérard is also Founder and President of MD Start, Chairman of Moon Surgical, Director of the Board of Pixium Vision and Limflow, and is Venture Partner at Sofinnova.

 

Philippe Boucheron,
representing Bpifrance Investissement

Investment Director at Bpifrance Investissement, Philippe graduated from École Polytechnique Montréal and holds a MBA from INSEAD. He has over 20 years of investment experience in life sciences.

 

Emmanuelle Coutanceau,
representing Novo Holdings

Partner at Novo Holdings, Emmanuelle has more than 10 years of venture capital experience. Before joining Novo Holdings, she was a partner at Auriga Partners, specializing in life sciences, and worked at Omnes Capital. She serves on the boards of Draupnir, Minervax, IO Biotech, Heparegenix and Inthera.

 

 

Clothilde Lauzeral,
representing Bpifrance’s SPI fund

Clothilde Lauzeral began her career as a Financial Consultant with EY. For six years, she assisted leading French and international groups and investment funds with their complex financial projects. In early 2018 she joined the Caisse des Dépôts et Consignations group, where she was in charge of managing a portfolio of strategic equity interests including CDC Habitat and Compagnie des Alpes (Board member). Since 2022, she has been an Investment Director for the SPI Fund at Bpifrance. Clothilde holds a Master 2 degree in Corporate Finance from the Paris Dauphine University.

Louis de Lillers,
CEO of CorWave

CEO of CorWave since 2015, Louis has over 10 years of experience in the fields of LVAD and venture capital. He previously co-founded PlugMed, a medtech company and worked at Clipperton Finance and Sofinnova Partners. Louis graduated from EDHEC Business School and holds a university degree in artificial heart and circulatory support from Pitié-Salpêtrière.

 

Raúl Martín-Ruiz,
representing Ysios Capital

Partner at Ysios Capital, Raúl graduated with a PhD degree in neurosciences. He has more than 25 years of experience in life sciences including academia, pharma and venture capital. He sits on the board of Anaconda Biomed, and previously of STAT Diagnostica (acquired by Qiagen), Prexton Therapeutics (acquired by Lundbeck) and MedLumics.

Marie Meynadier,
independent board member

A graduate from Sup Telecom with a doctorate from Ecole Normale Supérieure, she has more than 25 years of experience in the fields of medical technologies and high-tech. Over her career, Marie has led major national and international development programs that have led to the creation of several start-ups in the fields of electronics, optics and microelectronics. She has been exclusively dedicated to EOS imaging since 2008.

Anne Reiser,
representing EIC fund

Anne has decades of experience in the medtech industry. She notably spent 10 years at ResMed, a NYSE-listed medtech company, where she advanced to the global executive committee, serving as President of Europe and later overseeing the EMEA-APAC-Japan region. She played a key role in the company’s growth, contributing to its rise to the S&P 500 in July 2017. Anne has also gained solid knowledge of heart failure, having successfully developed at Medtronic the implantable defibrillator market in France in the 1990s. She holds a master’s degree in business from ESC Clermont-Ferrand, a law degree, and an Executive Master from Sciences Po Paris.